Results 321 to 330 of about 1,066,380 (380)

Synchronous Acute Ischemic Stroke and Acute Myocardial Infarction: A Case Report. [PDF]

Cureus
Grela I, Peterson TR.
europepmc   +1 more source

Metabolic changes during cardiac regeneration in the axolotl

Developmental Dynamics, EarlyView.
Abstract Background The axolotl is a prominent model organism of heart regeneration due to its ability to anatomically and functionally repair the heart after an injury that mimics human myocardial infarction. In humans, such an injury leads to permanent scarring. Cardiac regeneration has been linked to metabolism and the oxygenation state, but so far,
Anita Dittrich, Sofie Amalie Andersson, Morten Busk, Kasper Hansen, Casper Bindzus Foldager, Johan Palmfeldt, Asger Andersen, Michael Pedersen, Mikkel Vendelbo, Kirstine Lykke Nielsen, Henrik Lauridsen   +10 more
wiley   +1 more source

Amyloid β1-40 Predicts Long-Term Mortality Rate in Patients With Acute Myocardial Infarction. [PDF]

J Am Heart Assoc
Aleksova A, Fluca AL, Pierri A, Barbati G, Beltrami AP, Padoan L, Merro E, Marketou M, Zwas D, D'Errico S, Sinagra G, Janjusevic M.   +11 more
europepmc   +1 more source

Autopsy findings in cases of fatal COVID‐19 vaccine‐induced myocarditis

ESC Heart Failure, EarlyView.
Abstract COVID‐19 vaccines have been linked to myocarditis, which, in some circumstances, can be fatal. This systematic review aims to investigate potential causal links between COVID‐19 vaccines and death from myocarditis using post‐mortem analysis.
Nicolas Hulscher, Roger Hodkinson, William Makis, Peter A. McCullough   +3 more
wiley   +1 more source

Incident heart failure and recurrent coronary events following acute myocardial infarction. [PDF]

Eur Heart J
Butler J, Hammonds K, Talha KM, Alhamdow A, Bennett MM, Bomar JVA, Ettlinger JA, Traba MM, Priest EL, Schmedt N, Zeballos C, Shaver CN, Afzal A, Widmer RJ, Gottlieb RL, Mack MJ, Packer M.   +16 more
europepmc   +1 more source

The difficult discussion on the deactivation of implantable cardioverter devices at the end of life: a systematic review

ESC Heart Failure, Volume 12, Issue 2, Page 733-760, April 2025.
Abstract Implantable cardioverter defibrillators (ICDs) reliably prevent death due to life‐threatening arrhythmias; this may become less relevant in people with more severe heart failure who are reaching the end of life (EOL). This review aimed to explore the ICD deactivation process and identify ethical issues, especially around the initiation of ...
Siobhan C. Murray, Claire McNamara, Anna V. Chatzi   +2 more
wiley   +1 more source

Sex Differences in Non-Acute Myocardial Infarction Cardiogenic Shock: Insights from the Northwell-Shock Registry. [PDF]

J Clin Med
Li S, Adi A, Miller M, Sakr F, Jnani J, Rodriguez EA, Tan S, Mokhtari MB, Ramsis R, Smoller R, Stevens GR, Hernandez-Montfort J, Griffin M, Pierce M, Alvarez Villela M.   +14 more
europepmc   +1 more source

Systemic aging fuels heart failure: Molecular mechanisms and therapeutic avenues

ESC Heart Failure, Volume 12, Issue 2, Page 1059-1080, April 2025.
Abstract Systemic aging influences various physiological processes and contributes to structural and functional decline in cardiac tissue. These alterations include an increased incidence of left ventricular hypertrophy, a decline in left ventricular diastolic function, left atrial dilation, atrial fibrillation, myocardial fibrosis and cardiac ...
Zhuyubing Fang, Umar Raza, Jia Song, Junyan Lu, Shun Yao, Xiaohong Liu, Wei Zhang, Shujuan Li   +7 more
wiley   +1 more source

Severity of COPD in comparison with acute myocardial infarction: evidence of in-hospital mortality in Brazil. [PDF]

J Bras Pneumol
Rabahi MF, Saraiva G, Fernandes FLA, Rabe K.   +3 more
europepmc   +1 more source

Gut microbiota‐related modulation of immune mechanisms in post‐infarction remodelling and heart failure

ESC Heart Failure, Volume 12, Issue 2, Page 942-954, April 2025.
Abstract The immune system has long been recognized as a key driver in the progression of heart failure (HF). However, clinical trials targeting immune effectors have consistently failed to improve patient outcome across different HF aetiologies. The activation of the immune system in HF is complex, involving a broad network of pro‐inflammatory and ...
Johann Roessler, Friederike Zimmermann, Bettina Heidecker, Ulf Landmesser, Arash Haghikia   +4 more
wiley   +1 more source